EMAIL THIS PAGE TO A FRIEND

European journal of gynaecological oncology

Sentinel lymph node detection by intranipple injection of patent blue dye in breast cancer: a preliminary report of a feasibility study.


PMID 22873105

Abstract

Sentinel lymph node (SLN) biopsy is a well established option for assessing axillary lymph node status in breast cancer. Several techniques have been applied so far (superficial or deeper ones). Based on anatomical features of the lymphatic drainage in the breast, we assessed the feasibility of an intranipple approach for SLN mapping. Our data support the feasibility of SLN detection by our technique, with a high rate of SLN identification, which could be used in clinical practice as an alternative to the peri-areolar approach.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

198218
Patent Blue VF, Dye content 50 %
C27H31N2NaO6S2
76357
Patent blue VF sodium salt, for microscopy
C27H31N2NaO6S2